Ken Griffin West Pharmaceutical Services Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 47,000 shares of WST stock, worth $14.8 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
47,000
Previous 32,700
43.73%
Holding current value
$14.8 Million
Previous $12.9 Million
19.65%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding WST
# of Institutions
828Shares Held
64.8MCall Options Held
345KPut Options Held
211K-
Vanguard Group Inc Valley Forge, PA8.94MShares$2.82 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY7.58MShares$2.39 Billion0.06% of portfolio
-
State Street Corp Boston, MA3.2MShares$1.01 Billion0.05% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.49MShares$784 Million1.3% of portfolio
-
Franklin Resources Inc San Mateo, CA2.47MShares$776 Million0.26% of portfolio
About WEST PHARMACEUTICAL SERVICES INC
- Ticker WST
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 74,033,000
- Market Cap $23.3B
- Description
- West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...